Physician profile
Erich William Walder
NPI 1023032927
$5,454.23
in general payments reported to CMS, 2019-2025
10 companies · $263 in 2025
The $263 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.81 · 2020: $15.46 · 2021: $221 · 2022: $817 · 2023: $197 · 2024: $3,894 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $1,124 · Food and Beverage: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $1,123.53 |
| Food and Beverage | $730.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,894.42 | 2024 | |
| Pulmonx Corporation | $944.64 | 2021-2023 | Zephyr Delivery Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Glaxosmithkline, LLC. | $290.10 | 2019-2025 | Nucala |
| Ethicon INC. | $116.97 | 2022-2023 | Monarch Platform |
| Regeneron Healthcare Solutions, INC. | $73.42 | 2023 | Dupixent |
| Medical Device Business Services, INC. | $40.40 | 2023 | Monarch |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.97 | 2019 | |
| Genzyme Corporation | $30.25 | 2023 | |
| Mallinckrodt Hospital Products INC. | $15.46 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.60 | 2023 | Breztri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erich Walder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.